CABERGOLINE 1MG / PER TAB – [ 4 TABLETS STRIP] – JOHN LEE PHARMA

Cabergoline, commonly known as Caberlee, is popularly used as a post cycle therapy drug which is manufactured by John Lee. Many bodybuilders who have mismanaged their androgenic steroid cycles and have suffered significant risk of side effects. Caberlee can help manage those side effects by restoring the natural level of hormones in the body. We offer, 4 tabs, 1mg/tab packaging with US domestic express delivery. This drug has been in use by health care specialists to treat patients suffering from hyperprolactinaemia or gynecomastia. Now bodybuilders are using this drug as a post cycle therapy drug to deal with the side effects of androgenic steroids. Caberlee is a powerful drug with dopamine effects which stimulates the production of testosterone. If the bodybuilder does not take caberlee after androgenic steroid cycle, there are high chances for the individual to develop side effects such as gynecomastia. Another reason that caberlee is popular amongst bodybuilders is because it can significantly burn fat and result in weight loss while balancing the natural hormone levels of the body.

Benefits:

Benefits of caberlee are limited for a bodybuilder but its single utility is significant. However, there are some added benefits that some users have expressed and they are:

Effective for two or more days after the end of administration
Greater bioactivity than other drugs
Increase in Libido
Actively burns fat
Promotes testosterone production

Dosage:

The standard dosage for caberlee is 0.5mg per week which can be increased, depending on the user’s serum prolactin level, to a maximum of 1mg per week after a consistent cycle of 4 weeks. This dosage caters to all levels of bodybuilders because it is just a post cycle therapy drug. This drug is not suitable for individuals who have serious underlying health conditions such as cardiovascular issues, addiction to dopamine etc. The dosage must be carefully calculated, therefore, consult an expert for an advice.